CBLN2 Polyclonal antibody

CBLN2 Polyclonal Antibody for WB, ELISA
Cat No. 20558-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IF, ELISA

CBLN2, Cerebellin 2, cerebellin 2 precursor

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration:  150 μL, 400 ug/ml
20 μL, 400 ug/ml
150 μL, 400 ug/ml

$449/ 150 μL

In stock in Rosemont, IL. Order within 3 hours and 54 mins to receive by Friday, June 20

Freight/Packing: $40.00

Quantity

Tested Applications

Positive WB detected inmouse brain tissue, rat brain tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20558-1-AP targets CBLN2 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide Predict reactive species
Full Name cerebellin 2 precursor
Calculated Molecular Weight 24 kDa
Observed Molecular Weight 24 kDa
GenBank Accession NumberNM_182511
Gene Symbol CBLN2
Gene ID (NCBI) 147381
RRIDAB_10694418
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDQ8IUK8
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for CBLN2 antibody 20558-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,ratWB,IF

Life Sci

Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway

Authors - E-Li Wang
humanWB

Int Immunopharmacol

CBLN2 overexpression inhibits colorectal cancer progression and improves immunotherapy responses

Authors - Zeyu Wang
Loading...